Zobrazeno 1 - 10 of 92 pro vyhledávání: '"Equiza J"'
1
Editorial & Opinion
Editorial comment on 'Impact on functional outcome of an adaptive Stroke Unit based system of care for patients undergoing endovascular treatment during pandemic times' by Equiza J et al. published European Stroke Journal.
Autor: Nolte CH; Klinik für Neurologie mit Experimenteller Neurologie and Center for Stroke Research Berlin (CSB) and Berlin Institute of Health (BIH), Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Publikováno v: European stroke journal [Eur Stroke J] 2022 Sep; Vol. 7 (3), pp. 257-258. Date of Electronic Publication: 2022 May 27.
Zobrazit plný text záznamu
5
Report
Further Evidence of Cerebellar Cognitive Affective/Schmahmann Syndrome in RFC1-Related Syndrome.
Autor: Albajar I; Department of Neurology, Osakidetza-Basque Health Service, Hospital Universitario Donostia, Donostia-San Sebastian, Spain., Iruzubieta P; Department of Neurology, Osakidetza-Basque Health Service, Hospital Universitario Donostia, Donostia-San Sebastian, Spain.; Neurosciences, Biogipuzkoa Health Research Institute, Donostia-San Sebastian, Spain.; CIBERNED (CIBER, Institute Carlos III), Madrid, Spain.; Faculty of Medicine, University of Deusto, Bilbao, Spain., Barandiaran M; CIBERNED (CIBER, Institute Carlos III), Madrid, Spain.; Department of Neurology, Neuropsychology, Osakidetza-Basque Health Service, Hospital Universitario Donostia, Donostia-San Sebastian, Spain., Alves P; Department of Neurology, Neuropsychology, Osakidetza-Basque Health Service, Hospital Universitario Donostia, Donostia-San Sebastian, Spain.; Neurodegenerative Diseases Group, Biogipuzkoa Health Research Institute, Donostia-San Sebastian, Spain., Pujol A; Neurometabolic Disease Lab, Hospital Duran i Reynals, IDIBELL Gran Via 199, 08908 L'Hospitalet de Llobregat, Institut d'Investigacio Biomedica de Bellvitge, Barcelona, Spain.; CIBERER (CIBER, Institute Carlos III), Madrid, Spain., Verdura E; Neurometabolic Disease Lab, Hospital Duran i Reynals, IDIBELL Gran Via 199, 08908 L'Hospitalet de Llobregat, Institut d'Investigacio Biomedica de Bellvitge, Barcelona, Spain.; CIBERER (CIBER, Institute Carlos III), Madrid, Spain., Equiza J; Department of Neurology, Osakidetza-Basque Health Service, Hospital Universitario Donostia, Donostia-San Sebastian, Spain.; Neurological Intensive Care Unit, Montreal Neurological Institute-Hospital, McGill University, Montreal, Quebec, Canada., Urreta I; Clinical Epidemiology Unit, Osakidetza-Basque Health Service, Hospital Universitario Donostia, Donostia-San Sebastian, Spain.; Clinical Epidemiology, Biogipuzkoa Health Research Institute, Donostia-San Sebastian, Spain., Ruiz-Martínez J; Department of Neurology, Osakidetza-Basque Health Service, Hospital Universitario Donostia, Donostia-San Sebastian, Spain.; Neurosciences, Biogipuzkoa Health Research Institute, Donostia-San Sebastian, Spain.; CIBERNED (CIBER, Institute Carlos III), Madrid, Spain., Maneiro M; Department of Neurology, Osakidetza-Basque Health Service, Hospital Universitario Donostia, Donostia-San Sebastian, Spain., Fernandez-Torron R; Department of Neurology, Osakidetza-Basque Health Service, Hospital Universitario Donostia, Donostia-San Sebastian, Spain.; CIBERNED (CIBER, Institute Carlos III), Madrid, Spain.; Faculty of Medicine, University of Deusto, Bilbao, Spain., Poza JJ; Department of Neurology, Osakidetza-Basque Health Service, Hospital Universitario Donostia, Donostia-San Sebastian, Spain.; CIBERNED (CIBER, Institute Carlos III), Madrid, Spain.; Faculty of Medicine, University of Deusto, Bilbao, Spain., Mondragón E; Department of Neurology, Osakidetza-Basque Health Service, Hospital Universitario Donostia, Donostia-San Sebastian, Spain., de Munain AL; Department of Neurology, Osakidetza-Basque Health Service, Hospital Universitario Donostia, Donostia-San Sebastian, Spain.; CIBERNED (CIBER, Institute Carlos III), Madrid, Spain.; Faculty of Medicine, University of Deusto, Bilbao, Spain.; Neurosciences, Biodonostia Health Research Institute, Donostia-San Sebastian, Spain.
Publikováno v: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2024 Jul; Vol. 39 (7), pp. 1246-1248.
Zobrazit plný text záznamu
6
Akademický článek
Frequency and phenotypic spectrum of spinocerebellar ataxia 27B and other genetic ataxias in a Spanish cohort of late-onset cerebellar ataxia.
Autor: Iruzubieta P; Department of Neurology, Donostia University Hospital, Biodonostia Health Research Institute, Donostia-San Sebastián, Spain.; CIBERNED Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas-Instituto de Salud Carlos III (CIBER-CIBERNED-ISCIII), Madrid, Spain.; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology London and The National Hospital for Neurology and Neurosurgery, University College London, London, UK., Pellerin D; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology London and The National Hospital for Neurology and Neurosurgery, University College London, London, UK.; Department of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal, Quebec, Canada., Bergareche A; Department of Neurology, Donostia University Hospital, Biodonostia Health Research Institute, Donostia-San Sebastián, Spain.; CIBERNED Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas-Instituto de Salud Carlos III (CIBER-CIBERNED-ISCIII), Madrid, Spain., Albajar I; Department of Neurology, Donostia University Hospital, Biodonostia Health Research Institute, Donostia-San Sebastián, Spain., Mondragón E; Department of Neurology, Donostia University Hospital, Biodonostia Health Research Institute, Donostia-San Sebastián, Spain.; CIBERNED Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas-Instituto de Salud Carlos III (CIBER-CIBERNED-ISCIII), Madrid, Spain., Vinagre A; Department of Neurology, Donostia University Hospital, Biodonostia Health Research Institute, Donostia-San Sebastián, Spain.; CIBERNED Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas-Instituto de Salud Carlos III (CIBER-CIBERNED-ISCIII), Madrid, Spain., Fernández-Torrón R; Department of Neurology, Donostia University Hospital, Biodonostia Health Research Institute, Donostia-San Sebastián, Spain.; CIBERNED Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas-Instituto de Salud Carlos III (CIBER-CIBERNED-ISCIII), Madrid, Spain., Moreno F; Department of Neurology, Donostia University Hospital, Biodonostia Health Research Institute, Donostia-San Sebastián, Spain.; CIBERNED Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas-Instituto de Salud Carlos III (CIBER-CIBERNED-ISCIII), Madrid, Spain., Equiza J; Department of Neurology, Donostia University Hospital, Biodonostia Health Research Institute, Donostia-San Sebastián, Spain., Campo-Caballero D; Department of Neurology, Donostia University Hospital, Biodonostia Health Research Institute, Donostia-San Sebastián, Spain., Poza JJ; Department of Neurology, Donostia University Hospital, Biodonostia Health Research Institute, Donostia-San Sebastián, Spain., Ruibal M; Department of Neurology, Donostia University Hospital, Biodonostia Health Research Institute, Donostia-San Sebastián, Spain., Formica A; Department of Neurology, Donostia University Hospital, Biodonostia Health Research Institute, Donostia-San Sebastián, Spain., Dicaire MJ; Department of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal, Quebec, Canada., Danzi MC; Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, Florida, USA., Zuchner S; Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, Florida, USA., Croitoru I; CIBERNED Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas-Instituto de Salud Carlos III (CIBER-CIBERNED-ISCIII), Madrid, Spain., Ruiz M; Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Centre for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain., Schlüter A; Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Centre for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain., Casasnovas C; Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Neuromuscular Unit, Neurology Department, Hospital Universitari de Bellvitge, Universitat de Barcelona, Barcelona, Spain., Pujol A; Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Centre for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Catalan Institution of Research and Advanced Studies (ICREA), Barcelona, Spain., Brais B; Department of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal, Quebec, Canada.; Department of Human Genetics, McGill University, Montreal, Quebec, Canada., Houlden H; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology London and The National Hospital for Neurology and Neurosurgery, University College London, London, UK., López de Munain A; Department of Neurology, Donostia University Hospital, Biodonostia Health Research Institute, Donostia-San Sebastián, Spain.; CIBERNED Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas-Instituto de Salud Carlos III (CIBER-CIBERNED-ISCIII), Madrid, Spain., Ruiz-Martínez J; Department of Neurology, Donostia University Hospital, Biodonostia Health Research Institute, Donostia-San Sebastián, Spain.; CIBERNED Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas-Instituto de Salud Carlos III (CIBER-CIBERNED-ISCIII), Madrid, Spain.
Publikováno v: European journal of neurology [Eur J Neurol] 2023 Dec; Vol. 30 (12), pp. 3828-3833. Date of Electronic Publication: 2023 Aug 27.
Zobrazit plný text záznamu
7
Akademický článek
Posterior Circulation Ischemic Stroke Due to Bilateral Petroclival Meningiomas.
Autor: Hevia-Rodríguez P; From the Departments of Neurosurgery (P.H.-R., J.E., I.d.-G., N.S.), Neurology (J.E.), and Radiology (M.A.-L.), Donostia University Hospital, San Sebastián, Spain. pelahevia@gmail.com., Equiza J; From the Departments of Neurosurgery (P.H.-R., J.E., I.d.-G., N.S.), Neurology (J.E.), and Radiology (M.A.-L.), Donostia University Hospital, San Sebastián, Spain., Alonso-Lacabe M; From the Departments of Neurosurgery (P.H.-R., J.E., I.d.-G., N.S.), Neurology (J.E.), and Radiology (M.A.-L.), Donostia University Hospital, San Sebastián, Spain., de Goñi I; From the Departments of Neurosurgery (P.H.-R., J.E., I.d.-G., N.S.), Neurology (J.E.), and Radiology (M.A.-L.), Donostia University Hospital, San Sebastián, Spain., Samprón N; From the Departments of Neurosurgery (P.H.-R., J.E., I.d.-G., N.S.), Neurology (J.E.), and Radiology (M.A.-L.), Donostia University Hospital, San Sebastián, Spain.
Publikováno v: Neurology [Neurology] 2023 Nov 07; Vol. 101 (19), pp. 855-856. Date of Electronic Publication: 2023 Aug 14.
Zobrazit plný text záznamu
8
Frequency, Predictors, Etiology, and Outcomes for Deep Intracerebral Hemorrhage without Hypertension
Autor: Prats-Sánchez L., Iruzubieta P., Vesperinas A., Collet R., Martínez-Domeño A., Guisado-Alonso D., Camps-Renom P., Delgado-Mederos R., Guasch-Jiménez M., Ramos-Pachón A., Rodríguez-Antigüedad J., Campo-Caballero D., Equiza J., de la Riva P., Martínez-Zabaleta M., de Arce A., Martí-Fàbregas J.
Publikováno v: Journal of Stroke & Cerebrovascular Diseases
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Objectives: Some patients with deep intracerebral hemorrhage (ICH) have a transient hypertensive response and they may be erroneously classified as secondary to hypertension. We investigated frequency, risk factors, and outcomes for patients with dee
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::490e57007ec6d9617e209a82327f99d1
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85122428010&doi=10.1016/j.jstrokecerebrovasdis.2021.106293&partnerID=40&md5=1928fd6630de0b9b615f5ee0473811f4
Zobrazit plný text záznamu
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje